Current CTO of Biotheus. Ph.D. from Brandeis University, USA, post-doctorate at Harvard Medical School. Joanne has more than 20 years of rich experience in quality research and quality control for antibody biopharmaceutical discovery, development and launching. She has successively served as R&D executives in Abbott, Bristol-Myers Squibb, Adimab, etc., and participated in the development and quality research of many international best-selling antibody drugs. After returning to China in 2012, she served as vice president of Innovent Biologics, where she successfully established and led a quality, analysis and transfer medical team, and made significant contributions to establishment of quality system, internationalization of product quality and creation of rich product pipelines.